(Q31099184)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Jacques Van Dongen

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

V H J van der Velden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

G Cazzaniga

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

A Schrauder

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

J Hancock

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

P Bader

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

E R Panzer-Grumayer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

T Flohr

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

R Sutton

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

H O Madsen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

J M Cayuela

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

J Trka

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

C Eckert

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

L Foroni

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

U Zur Stadt

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

K Beldjord

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

T Raff

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

European Study Group on MRD detection in ALL (ESG-MRD-ALL)

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

C E van der Schoot

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

8 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

604-611

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

New definition of remission in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

T-lymphocytes in bone marrow samples of children with acute lymphoblastic leukemia during and after chemotherapy might hamper PCR-based minimal residual disease studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Inhibition affecting RQ-PCR-based assessment of minimal residual disease in acute lymphoblastic leukemia: reversal by addition of bovine serum albumin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404586

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404586

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287850%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

25 December 2019

1021226556

0 references

1 reference